CD8A and neoplasm: These data are of interest, as they suggest a role for CD8 T-cells in synergising with radiotherapy (RT) to improve antitumour immunity in ER+ tumours, which have relatively low numbers of TILs present, independent of treatment, tumour grade, margin status or a cavity boost.